icon-folder.gif   Conference Reports for NATAP  
 
  17th European AIDS Conference
November 6-9
2019, Basel
Back grey_arrow_rt.gif
 
 
 
Long-term Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir
Alafenamide in ART-Naïve Adults

 
 
  Reported by Jules Levin
17th European AIDS Conference, November 6-9, 2019, Basel, Switzerland
 
Chloe Orkin,1 Paul E. Sax,2 Jose Arribas,3 Samir Gupta,4 Claudia Martorell,5 Jeffrey L. Stephens,6 Hans-Jurgen Stellbrink,7 Edwin DeJesus,8 Franco Maggiolo,9 Hailin Huang,10 Rima Acosta,10 Diana M. Brainard,10 Sean E. Collins,10 Hal Martin,10 on behalf of the Study 1489 and 1490 Investigators
1Barts Health NHS Trust, London, UK; 2Brigham and Women's Hospital, Boston, Massachusetts, USA; 3Hospital Universitario La Paz, Madrid, Spain; 4Indiana University School of Medicine, Indianapolis, Indiana, USA; 5Infectious Disease and The Research Institute, Springfield, Massachusetts; 6Mercer University School of Medicine, Macon, Georgia, USA; 7ICH Study Center, Hamburg, Germany; 8Orlando Immunology Center, Orlando, Florida, USA; 9ASST Papa Giovanni XXIII, Bergamo, Italy; 10Gilead Sciences, Inc., Foster City, California, USA

1108191

1108192

1108193

1108194

1108195

1108196

1108197

1108198